Columbus Venture Partners

Columbus Venture Partners is a Spanish venture capital fund manager specialising in life sciences. Founded in 2016 by Javier García Cogorro and Damià Tormo, the firm invests in therapeutic and industrial biotechnology through a platform of four investment funds. Its stated focus is on therapies for hard-to-treat, rare and incurable diseases, with technical activity spanning gene therapy, cancer treatments and biomanufacturing.

The firm describes a dual mandate: financing early-stage therapeutic projects and originating healthcare businesses, while also building the industrial infrastructure and capabilities that support them. This extends beyond conventional company formation - the platform also backs technologies serving healthcare and constructs industrial biotech capacity, a model more often associated with build-to-scale operators than with pure financial investors.

The track record covers some 50 biotechnology companies since inception in 2016. Investment is concentrated in Spain, and the sectoral emphasis spans therapeutics, rare diseases, oncology and gene therapy alongside industrial biotechnology. The stated objective is to bring scientific advances closer to patients while generating returns for investors.

Further detail on fund structure, investment stage and terms is set out at columbusvp.com.